深圳欣博盛生物科技有限公司

VEGF Receptor 2 antibody [260.4(KDR-2)]

kinase insert domain receptor , CD309 , FLK1 , VEGFR , VEGFR2

Human

Mouse

ELISA, IHC-Fr, WB

Reacts specifically with human VEGF receptor-2. This clone has also been termed 260.4. It does not recognize Flt1 (VEGFR-1), Flt4 (VEGFR-3), or platelet-derived growth factor receptor (PDGF-R).

IgG1

purified recombinant human extracellular VEGF receptor-2 (KDR).

Monoclonal

260.4(KDR-2)

Unpurified

Unconjugated

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

4°C

152

Liquid

Ascites, 15mM Sodium azide.

GeneTex

Vascular endothelial growth factor (VEGF), also called vasculotropin (VAS) and vascular permeability factor (VPF), is a member of a family of endothelial cell mitogenic and angiogenic factors. VEGF is a homodimeric heparin-binding glycoprotein, that specifically stimulates the proliferation of endothelial cells isolated from both small and large vessels. These include endothelial cells from adrenal cortex, cerebral cortex, fetal and adult aorta and human umbilical vein. The mitogenic activity of VEGF appears to be stimulated by specific VEGF receptors (110 kDa) which can be found on the surface of various endothelial cells. VEGF binds to two structurally similar receptor tyrosine kinases; Flt15 (fms-like tyrosine kinase 1) also known as VEGF Receptor 1 and KDR6 (kinase-insert domain containing receptor) known as VEGF Receptor 2. The homologous gene for the human KDR gene is mouse Flk1 (fetal liver kinase 1) and rat TKrc. Both receptors are members of a superfamily of receptor tyrosine kinases (RTKs) which include PDGF receptor, c-fms, M-CSF receptor and c-kit - the receptor for stem-cell factor. The KDR gene has been mapped to human chromosome 4q11-q12, which is the same locus for PDGF receptor and c-kit. The extracellular domain of KDR/Flk1 and Flt1 (approx. 90 kDa), has seven immunoglobulin-like domains and belongs to the class V RTKs. This family includes also Flt4, which shares a high homology with the two VEGF receptors. Studies using KDR and Flt1 stably transfected endothelial cell lines have shown that these two receptors exhibit different affinities to VEGF and mediate different responses. KDR expressing cells show striking changes in cell morphology, actin reorganization and membrane ruffling, chemotaxis and mitogenicity in response to VEGF, while Flt1 expressing cells lack such responses. Both KDR and Flt1 are phosphorylated in response to VEGF, however KDR phosphorylation is much more efficient. KDR/Flk1 does not respond to placental growth factor (PlGF), a VEGF related growth factor, while Flt1 binds PlGF specifically. The expression pattern of the two receptors is somewhat different; Flt1 is predominately expressed in human placenta and human vascular endothelial cells, while KDR is more widely expressed in all vessel-derived endothelial cells but low in human and fetal bovine placenta. Antibodies that react specifically with VEGF receptor are useful for the study of the specific differential tissue expression and intracellular localization of the receptor in normal and neoplastic tissue.